One of these targets, PSEN1, contained the predicted binding site for hsa-miR-185-5p (Fig. 4H); the same was applied to GSK3B (glycogen synthase kinase 3 beta), another key player in AD pathology, which regulates APP and PSEN1 [43]. Here, APP is linked to Alzheimer disease.